TOMMASI, CHIARA
 Distribuzione geografica
Continente #
AS - Asia 1.061
NA - Nord America 899
EU - Europa 537
SA - Sud America 192
AF - Africa 92
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.784
Nazione #
US - Stati Uniti d'America 858
SG - Singapore 417
VN - Vietnam 243
CN - Cina 202
BR - Brasile 141
IT - Italia 124
HK - Hong Kong 95
IE - Irlanda 91
DE - Germania 64
ZA - Sudafrica 56
FR - Francia 49
SE - Svezia 44
NL - Olanda 35
GB - Regno Unito 24
AR - Argentina 22
AT - Austria 19
FI - Finlandia 16
CA - Canada 15
ES - Italia 15
IN - India 13
RU - Federazione Russa 13
MX - Messico 12
PL - Polonia 12
BD - Bangladesh 11
IQ - Iraq 11
JP - Giappone 10
PH - Filippine 9
CI - Costa d'Avorio 8
EC - Ecuador 8
PK - Pakistan 8
TR - Turchia 8
EG - Egitto 7
BE - Belgio 6
CO - Colombia 6
CZ - Repubblica Ceca 6
ID - Indonesia 5
MA - Marocco 5
TN - Tunisia 5
VE - Venezuela 5
PE - Perù 4
TW - Taiwan 4
UZ - Uzbekistan 4
DZ - Algeria 3
MY - Malesia 3
NG - Nigeria 3
PA - Panama 3
PY - Paraguay 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
BG - Bulgaria 2
CL - Cile 2
DO - Repubblica Dominicana 2
GH - Ghana 2
HU - Ungheria 2
JM - Giamaica 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LT - Lituania 2
LV - Lettonia 2
PT - Portogallo 2
SA - Arabia Saudita 2
UA - Ucraina 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CH - Svizzera 1
CR - Costa Rica 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KE - Kenya 1
KG - Kirghizistan 1
LY - Libia 1
MD - Moldavia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
RO - Romania 1
SN - Senegal 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.784
Città #
Singapore 236
Ashburn 180
San Jose 102
Hong Kong 91
Dublin 90
Santa Clara 86
Ho Chi Minh City 72
Chandler 64
Beijing 60
Dallas 58
Hanoi 58
Johannesburg 51
Boardman 39
Shanghai 35
Parma 28
Munich 25
Lauterbourg 23
Los Angeles 22
New York 22
Hefei 19
Vienna 18
Frankfurt am Main 15
Buffalo 14
Haiphong 12
Bologna 11
São Paulo 11
Da Nang 10
Milan 10
Council Bluffs 9
Tokyo 9
Abidjan 8
Montreal 8
Nuremberg 8
Turku 8
Phoenix 7
Princeton 7
Ravenna 7
Warsaw 7
Atlanta 6
Baghdad 6
Bremen 6
Des Moines 6
Seattle 6
Amsterdam 5
Columbus 5
Düsseldorf 5
Ha Long 5
Helsinki 5
Marseille 5
Modena 5
Moscow 5
Reggio Emilia 5
Sassuolo 5
Stockholm 5
Toronto 5
Ann Arbor 4
Belo Horizonte 4
Brasília 4
Brooklyn 4
Brussels 4
Buenos Aires 4
Cascina 4
Denver 4
Manaus 4
Rio de Janeiro 4
Tashkent 4
Thái Nguyên 4
Wilmington 4
Barcelona 3
Bexley 3
Biên Hòa 3
Boston 3
Cape Town 3
City of London 3
Collecchio 3
Hyderabad 3
Istanbul 3
Jakarta 3
London 3
Madrid 3
Manchester 3
Newark 3
Olomouc 3
Providence 3
Querétaro 3
Quito 3
Rome 3
Santo André 3
Shenzhen 3
The Dalles 3
Thái Bình 3
Verona 3
Vũng Tàu 3
Woodbridge 3
Accra 2
Almaty 2
Ankara 2
Apodaca 2
Aracaju 2
Bangkok 2
Totale 1.772
Nome #
SARS-CoV-2 Infection Risk and COVID-19 Prevalence and Mortality in Cancer Patients During the First Wave of COVID-19 Pandemic in a Virus Epicenter in Northern Italy 161
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma 152
Biological Role and Clinical Implications of microRNAs in BRCA Mutation Carriers 145
Genetic Basis of Breast and Ovarian Cancer: Approaches and Lessons Learnt from Three Decades of Inherited Predisposition Testing 144
A review of immune checkpoint blockade in breast cancer 124
Nab-paclitaxel after docetaxel hypersensitivity reaction: case report and literature review 121
My best choice after a round trip from illness 116
Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score 115
Prognostic significance of germline BRCA mutations in patients with HER2-POSITIVE breast cancer 113
A narrative review of the principal glucocorticoids employed in cancer 113
Synchronous and metachronous colorectal liver metastases: Impact of primary tumor location on patterns of recurrence and survival after hepatic resection 111
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016) 107
Functional HRD by RAD51 identifies BRCA1 VUS associated with loss of gene function and response to DNA-damaging agents 104
Nivolumab-Induced Guillain-Barré Syndrome Coupled With Remarkable Disease Response in a Case of Heavily Pretreated Lung Adenocarcinoma 104
Long-Term Effects of Breast Cancer Therapy and Care: Calm after the Storm? 102
The future potential of genome-wide mutational profiles in HRD detection in breast cancer 100
Hormone Receptor-Positive/HER2-Positive Breast Cancer: Hormone Therapy and Anti-HER2 Treatment: An Update on Treatment Strategies 93
Burnout and Oncology: an irreparable paradigm or a manageable condition? Prevention strategies to reduce Burnout in Oncology Health Care Professionals 90
Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome? 88
Bridging bench to bedside: The evolution and impact of translational research in oncology. The experience of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) 85
The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma 84
Abscopal effect as part of treatment of oligometastatic head and neck cancer: A case report 77
Tissue Biomarkers in Gastric Cancer Treatment: Present and Future 68
The Innate Immune Microenvironment in Metastatic Breast Cancer 68
State of the art for metastatic pancreatic cancer treatment: Where are we now?* 68
The emerging predictive and prognostic role of HER2 in HER2-negative early breast cancer: a retrospective study 64
Noncoding RNAs emerging as novel biomarkers in pancreatic cancer 60
The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study 48
Totale 2.825
Categoria #
all - tutte 10.351
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.351


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 1 0 3
2021/202251 0 0 5 6 4 4 10 2 0 1 0 19
2022/2023276 27 21 18 14 37 29 3 14 91 2 15 5
2023/2024216 8 29 3 3 14 35 23 15 12 26 21 27
2024/2025707 36 29 43 34 59 73 30 38 77 79 55 154
2025/20261.550 148 153 194 152 217 96 153 68 242 127 0 0
Totale 2.825